BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9620315)

  • 21. A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis.
    Tuaillon N; Andre C; Briand JP; Penner E; Muller S
    J Immunol; 1992 Jan; 148(2):445-50. PubMed ID: 1729364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.
    Bogdanos DP; Baum H; Gunsar F; Arioli D; Polymeros D; Ma Y; Burroughs AK; Vergani D
    Scand J Gastroenterol; 2004 Oct; 39(10):981-7. PubMed ID: 15513338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)].
    Moteki S; Amaki S; Nakano E
    Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases.
    Matsumura S; Van De Water J; Kita H; Coppel RL; Tsuji T; Yamamoto K; Ansari AA; Gershwin ME
    Hepatology; 2002 Jan; 35(1):14-22. PubMed ID: 11786955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.
    Berg CP; Stein GM; Klein R; Pascu M; Berg T; Kammer W; Priemer M; Nordheim A; Schulze-Osthoff K; Gregor M; Wesselborg S; Berg PA
    Liver Int; 2006 Sep; 26(7):846-55. PubMed ID: 16911468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes.
    Leung PS; Cha S; Joplin RE; Galperin C; Van de Water J; Ansari AA; Coppel RL; Schatz PJ; Cwirla S; Fabris LE; Neuberger JM; Gershwin ME
    J Autoimmun; 1996 Dec; 9(6):785-93. PubMed ID: 9115581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
    Ikuno N; Scealy M; Davies JM; Whittingham SF; Omagari K; Mackay IR; Rowley MJ
    Hepatology; 2001 Sep; 34(3):478-86. PubMed ID: 11526532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis.
    Kaplan MM
    Am J Gastroenterol; 2004 Nov; 99(11):2147-9. PubMed ID: 15554995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognize two distinct autoepitopes in the E2 component of the pyruvate dehydrogenase complex.
    Matsui M; Nakamura M; Ishibashi H; Koike K; Kudo J; Niho Y
    Hepatology; 1993 Nov; 18(5):1069-77. PubMed ID: 7693571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY; Rowley MJ; Mackay IR
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic.
    Sasaki M; Ansari A; Pumford N; van de Water J; Leung PS; Humphries KM; Szweda LI; Nakanuma Y; Roche TE; Coppel RL; Bach JF; Gershwin ME
    J Autoimmun; 2000 Aug; 15(1):51-60. PubMed ID: 10936028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
    Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid.
    Amano K; Leung PS; Rieger R; Quan C; Wang X; Marik J; Suen YF; Kurth MJ; Nantz MH; Ansari AA; Lam KS; Zeniya M; Matsuura E; Coppel RL; Gershwin ME
    J Immunol; 2005 May; 174(9):5874-83. PubMed ID: 15845458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display.
    Rowley MJ; Scealy M; Whisstock JC; Jois JA; Wijeyewickrema LC; Mackay IR
    J Immunol; 2000 Mar; 164(6):3413-9. PubMed ID: 10706737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC.
    Fukushima N; Nalbandian G; Van De Water J; White K; Ansari AA; Leung P; Kenny T; Kamita SG; Hammock BD; Coppel RL; Stevenson F; Ishibashi H; Gershwin ME
    Hepatology; 2002 Dec; 36(6):1383-92. PubMed ID: 12447863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.
    Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME
    Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.
    Tsuneyama K; Van de Water J; Leung PS; Cha S; Nakanuma Y; Kaplan M; De Lellis R; Coppel R; Ansari A; Gershwin ME
    Hepatology; 1995 Apr; 21(4):1031-7. PubMed ID: 7535733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards the pathogenesis of autoimmune liver disease.
    Mackay IR; Davies JM; Rowley MJ
    J Autoimmun; 1999 Aug; 13(1):163-9. PubMed ID: 10441182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prediction and identification of autoepitopes of PDC-E2 specific CD8+ CTL in primary biliary cirrhosis patients].
    Liu HY; Yao DK; Tu XQ; Zhou Y; Zhu Y; Chen Y; Fan LY; Zhong RQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):500-4. PubMed ID: 15562760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis.
    Rowley MJ; McNeilage LJ; Armstrong JM; Mackay IR
    Clin Immunol Immunopathol; 1991 Sep; 60(3):356-70. PubMed ID: 1713816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.